clenbuterol has been researched along with Body Weight in 95 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment begins at the 4th day after tumor inoculation, at the 14th day they were killed, glycemia, lacticidemia, glycogen content from liver, soleus and gastrocnemius muscles, tumor mass, body weight and kidney function were determined." | 7.72 | Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. ( Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E, 2003) |
| "The present study was conducted to determine the effect of chronic administration of the long-acting beta(2)-adrenergic agonist clenbuterol on rats that are genetically prone to insulin resistance and impaired glucose tolerance." | 7.71 | Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. ( Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ, 2001) |
| "Clenbuterol induces significant hypertrophy of the LDM associated with specific changes in cardiac gene expression." | 7.69 | Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. ( Boheler, KR; Petrou, M; Wynne, DG; Yacoub, MH, 1995) |
| "This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats." | 7.68 | Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. ( Banks, EA; Brozinick, JT; Cortez, MY; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "The object of this experiment was to examine whether the administration of clenbuterol exerts clenbuterol's repartitioning effects in rats with hypothyroidism induced by the oral administration of propylthiouracil (PTU)." | 7.68 | Effect of beta agonist clenbuterol on the body composition of rats with hypothyroidism induced by oral administration of propylthiouracil. ( Katsumata, M; Miyazaki, A; Yano, H, 1991) |
| " We reported that clenbuterol (CB) induced masseter muscle hypertrophy and slow-to-fast myosin heavy chain (MHC) isoform transition through direct muscle β2-adrenergic receptor stimulation." | 3.81 | Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition. ( Fujita, T; Mototani, Y; Nakamura, Y; Ohnuki, Y; Okumura, S; Saeki, Y; Shiozawa, K; Suita, K; Umeki, D, 2015) |
| "Our data reveal that clenbuterol-induced skeletal muscle hypertrophy is unable to mimic the beneficial clinical effects of increased musculature derived through targeted strength training in humans, in a rodent model of MNX-induced OA." | 3.76 | Beta2-adrenergic agonist-induced hypertrophy of the quadriceps skeletal muscle does not modulate disease severity in the rodent meniscectomy model of osteoarthritis. ( Bardsley, R; Doherty, M; Jones, SW; Maciewicz, RA; Parr, T; Tonge, DP, 2010) |
| "The aim of this study was to analyze the effects of chronic administration of the beta-adrenoceptor agonist clenbuterol (2 mg/kg body weight/day for a period of 30 days) on the major contractile protein (myosin) in the left ventricular muscle of the adult mouse heart." | 3.74 | Chronic oral administration of beta-adrenoceptor agonist clenbuterol affects myosin heavy chain (MHC) expression in adult mouse heart. ( Patiyal, SN; Sharma, S, 2007) |
| "Chronic administration of clenbuterol, a beta-adrenoceptor agonist (2 mg/kg body weight/day for 30 days) to mice resulted in an increased body mass." | 3.73 | Tissue specific and variable collagen proliferation in Swiss albino mice treated with clenbuterol. ( Katoch, SS; Patiyal, SN, 2006) |
| " The regulatory mechanism for the hypertrophy of skeletal muscles induced by clenbuterol is unclear." | 3.73 | Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist. ( Akutsu, S; Shimada, A; Yamane, A, 2006) |
| " Treatment begins at the 4th day after tumor inoculation, at the 14th day they were killed, glycemia, lacticidemia, glycogen content from liver, soleus and gastrocnemius muscles, tumor mass, body weight and kidney function were determined." | 3.72 | Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. ( Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E, 2003) |
| " Hyperthyroidism was produced by three injections of 100 microg T3/100 g body weight on alternate days with or without concomitant treatment with either captopril (an angiotensin-converting enzyme [ACE] inhibitor), propranolol (a beta-blocker) or clenbuterol (a beta2-agonist)." | 3.72 | Effect of thyroid hormone on uncoupling protein-3 mRNA expression in rat heart and skeletal muscle. ( Ismail-Beigi, F; Queiroz, MS; Shao, Y, 2004) |
| "Post-treatment body weights and skeletal muscle weights were not affected by clenbuterol treatment." | 3.72 | Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles. ( Bigard, AX; Bricout, VA; Serrurier, BD, 2004) |
| "The present study was conducted to determine the effect of chronic administration of the long-acting beta(2)-adrenergic agonist clenbuterol on rats that are genetically prone to insulin resistance and impaired glucose tolerance." | 3.71 | Effects of clenbuterol on insulin resistance in conscious obese Zucker rats. ( Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ, 2001) |
| " We have studied the induction of cardiac hypertrophy after treatment with clenbuterol and the role of polyamines in this effect." | 3.70 | Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse. ( Balaña-Fouce, R; Cubría, JC; Ordóñez, C; Ordóñez, D; Reguera, R, 1998) |
| "The relationship between myogenin or MyoD expression and hypertrophy of the rat soleus produced either by clenbuterol and 3,3', 5-triiodo-L-thyronine (CT) treatment or by surgical overload was examined." | 3.70 | Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy. ( Greaser, ML; Mozdziak, PE; Schultz, E, 1998) |
| "Clenbuterol induces significant hypertrophy of the LDM associated with specific changes in cardiac gene expression." | 3.69 | Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. ( Boheler, KR; Petrou, M; Wynne, DG; Yacoub, MH, 1995) |
| "Injection of rats with the beta 2-adrenoceptor agonist clenbuterol (1 mg/kg/d for 15 days) stimulated an increase in body weight (9%) and protein (8%) and water (7%) content, but reduced food intake (4%) and epididymal fat pad mass (39%)." | 3.69 | Anabolic effects of clenbuterol after long-term treatment and withdrawal in t the rat. ( Cartañà, J; Rothwell, NJ; Segués, T; Stock, MJ; Yebras, M, 1994) |
| "Effects induced by long-term administration of clenbuterol at anabolic dosages (20 micrograms/kg of body weight for 40 days) on beta-adrenergic receptor (beta-AR) subtypes, estrogen receptors (ER), and progesterone receptors (PgR) in the reproductive system of female veal calves were investigated." | 3.69 | Down-regulation of beta-adrenergic receptors and up-regulation of estrogen and progesterone receptors induced in the reproductive system of female veal calves by dietary clenbuterol. ( Badino, P; Girardi, C; Novelli, A; Re, G, 1995) |
| "The object of this experiment was to examine whether the administration of clenbuterol exerts clenbuterol's repartitioning effects in rats with hypothyroidism induced by the oral administration of propylthiouracil (PTU)." | 3.68 | Effect of beta agonist clenbuterol on the body composition of rats with hypothyroidism induced by oral administration of propylthiouracil. ( Katsumata, M; Miyazaki, A; Yano, H, 1991) |
| "The effects of clenbuterol, a beta 2-adrenergic agonist, on body weight, tissue masses, and protein and RNA contents were studied following scald injury (30 per cent TBSA) in the rat." | 3.68 | Clenbuterol, a beta 2-adrenergic agonist, reverses muscle wasting due to scald injury in the rat. ( Fisher, MI; Little, RA; Martineau, L; Rothwell, NJ, 1993) |
| "The effects of a beta 2-adrenoceptor agonist, clenbuterol, on body weight and protein metabolism of gastrocnemius muscle, heart, and liver were studied in rats subjected to 50% food restriction or fasting." | 3.68 | Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat. ( Choo, JJ; Horan, MA; Little, RA; Rothwell, NJ, 1990) |
| "The effects of aerobic exercise training, chronic administration of the selective beta 2-adrenergic agonist clenbuterol, and the combination of these two treatments on muscle insulin resistance were compared in female obese (fa/fa) Zucker rats." | 3.68 | Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle. ( Brozinick, JT; Etgen, GJ; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "This study compared the effects of aerobic exercise training and chronic administration of the selective beta 2-adrenergic agonist clenbuterol on whole body and skeletal muscle insulin resistance in obese (fa/fa) Zucker rats." | 3.68 | Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats. ( Banks, EA; Brozinick, JT; Cortez, MY; Ivy, JL; Torgan, CE; Wilcox, RE, 1993) |
| "5, 25, and 50 micrograms of clenbuterol HCl/kg of body weight/d for 21 days." | 3.68 | Effects of long-term administration of clenbuterol in mature female rats. ( Badino, P; Biolatti, B; Dacasto, M; Di Carlo, F; Girardi, C; Nebbia, C; Re, G, 1993) |
| " The influence has been studied of a beta-agonist, clenbuterol, on body weight increase, feed efficiency and muscular tissue growth in Wistar rats of two different weights (70 and 200 g) fed with a diet of differing protein levels (4, 10 and 15%)." | 3.68 | Influence of dietary protein level on growth: effect of clenbuterol. ( Peréz-Llamas, F; Sastre, JF; Zamora, S, 1991) |
| "Chronic treatment of rats with the beta 2-adrenergic agonists clenbuterol and fenoterol over 16-19 d raised energy intake, expenditure, and body weight gain but did not affect fat or energy deposition, and body protein gain was increased by 50 and 18%, respectively." | 3.67 | Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat. ( Emery, PW; Rothwell, NJ; Stock, MJ; Winter, PD, 1984) |
| " Two groups (n=16 for each) of 3-month-old male Wistar rats (UCL: untrained clenbuterol, and ECL: exercised clenbuterol) received a chronic administration of clenbuterol (2 mg/kg body weight/day)." | 1.34 | Molecular impact of clenbuterol and isometric strength training on rat EDL muscles. ( Cavalié, H; Clottes, E; Lac, G; Mounier, R, 2007) |
| "Clenbuterol treatment further reduced bone mineral density." | 1.33 | Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. ( Arlettaz, A; Benhamou, CL; Bonnet, N; Brunet-Imbault, B; Collomp, K; Courteix, D; Horcajada, MN; Richard, O; Vico, L, 2005) |
| "Clenbuterol was added to the drinking water (30 mg L(-1)) of adult male Wistar rats for 4 weeks." | 1.31 | Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres. ( Imoto, K; Matsumoto, H; Ogata, T; Oishi, Y; Roy, RR; Taniguchi, K, 2002) |
| "Clenbuterol-treated rats also showed a reduction in growth when compared to P rats (P = 3." | 1.30 | Increase in skeletal muscle protein content by the beta-2 selective adrenergic agonist clenbuterol exacerbates hypoalbuminemia in rats fed a low-protein diet. ( Lunn, PG; Sawaya, AL, 1998) |
| "5." | 1.29 | Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. ( Hayes, A; Williams, DA, 1994) |
| "Post-treatment body weights were approximately 5% greater in the CL group compared to CON (P < 0." | 1.29 | Clenbuterol-induced fiber type transition in the soleus of adult rats. ( Criswell, DS; Herb, RA; Powers, SK, 1996) |
| "Thus clenbuterol was more potent than salmeterol when given by this route of administration." | 1.29 | Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration. ( Moore, NG; Pegg, GG; Sillence, MN, 1994) |
| "Clenbuterol treatment had no statistically significant effect on accumulated food intake or body composition in the adult mice." | 1.29 | The effect of clenbuterol on body composition in spontaneously eating tumour-bearing mice. ( Hyltander, A; Lundholm, K; Svaninger, G, 1993) |
| "Clenbuterol treatment resulted in a reduction in the proportion of small diameter fibres, and therefore an increase in mean fibre diameter, in dystrophic EDL." | 1.29 | Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse. ( Agbenyega, ET; Hatton, PA; Morton, RH; Wareham, AC, 1995) |
| "Clenbuterol treatment increased the weight of skeletal muscles 22% to 39% in 3-month-old rats, 19% to 35% in 12-month-old rats, and 22% to 25% in 23-month-old animals." | 1.28 | Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats. ( Carter, WJ; Dang, AQ; Faas, FH; Lynch, ME, 1991) |
| ") I, fertility tests in male and female rats dosed before and during mating and the first week of gestation with 0." | 1.27 | Reproduction studies with mabuterol in rats. ( Daidohji, S; Horiguchi, T; Ishizaki, O; Kimura, K; Sekiwa, M; Shibuya, K, 1984) |
| " In subacute and chronic studies in Wistar rats, mabuterol was dosed by gavage at 0, 10, 20, 40, 80 and 120 mg/kg for 1 month, and 0, 1, 2." | 1.27 | Toxicology of mabuterol. ( Amemiya, K; Hosaka, K; Kudoh, M; Saga, K; Suzuki, H, 1984) |
| "Rats treated with clenbuterol for 18 days showed a 50% reduction in beta-receptor density, but the ratio of beta 1/beta 2-receptors was unaffected (15% beta 1/85% beta 2)." | 1.27 | Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol. ( Rothwell, NJ; Stock, MJ; Sudera, DK, 1987) |
| "The clenbuterol-induced increase in muscle growth in the insulin-replaced diabetic rats indicated that this beta-adrenergic agonist effect was not mediated by an alteration of circulating levels of insulin, secondary to beta-agonist action on pancreatic insulin release." | 1.27 | Clenbuterol-induced muscle growth: investigation of possible mediation by insulin. ( Barreto, A; Chaung, LY; McElligott, MA; Mulder, JE, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (21.05) | 18.7374 |
| 1990's | 46 (48.42) | 18.2507 |
| 2000's | 24 (25.26) | 29.6817 |
| 2010's | 5 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DM | 1 |
| Jones, S | 1 |
| Daniel, ZCTR | 1 |
| Brearley, MC | 1 |
| Lewis, JE | 1 |
| Ebling, FJP | 1 |
| Parr, T | 2 |
| Brameld, JM | 1 |
| Ishimaru, Y | 1 |
| Ijiri, D | 1 |
| Shimamoto, S | 1 |
| Ishitani, K | 1 |
| Nojima, T | 1 |
| Ohtsuka, A | 1 |
| Umeki, D | 1 |
| Ohnuki, Y | 1 |
| Mototani, Y | 1 |
| Shiozawa, K | 1 |
| Suita, K | 1 |
| Fujita, T | 1 |
| Nakamura, Y | 1 |
| Saeki, Y | 1 |
| Okumura, S | 1 |
| Tonge, DP | 1 |
| Jones, SW | 1 |
| Bardsley, R | 1 |
| Doherty, M | 1 |
| Maciewicz, RA | 1 |
| Ung, RV | 1 |
| Rouleau, P | 1 |
| Guertin, PA | 1 |
| Dodd, SL | 1 |
| Koesterer, TJ | 1 |
| Oishi, Y | 1 |
| Imoto, K | 1 |
| Ogata, T | 1 |
| Taniguchi, K | 1 |
| Matsumoto, H | 1 |
| Roy, RR | 1 |
| Piffar, PM | 1 |
| Fernandez, R | 2 |
| Tchaikovski, O | 1 |
| Hirabara, SM | 1 |
| Folador, A | 2 |
| Pinto, GJ | 1 |
| Jakobi, S | 1 |
| Gobbo-Bordon, D | 1 |
| Rohn, TV | 1 |
| Fabrício, VE | 1 |
| Moretto, KD | 1 |
| Tosta, E | 1 |
| Curi, R | 2 |
| Fernandes, LC | 2 |
| Page, KA | 1 |
| Hartzell, DL | 1 |
| Li, C | 1 |
| Westby, AL | 1 |
| Della-Fera, MA | 1 |
| Azain, MJ | 1 |
| Pringle, TD | 1 |
| Baile, CA | 1 |
| Bricout, VA | 1 |
| Serrurier, BD | 1 |
| Bigard, AX | 1 |
| Queiroz, MS | 1 |
| Shao, Y | 1 |
| Ismail-Beigi, F | 1 |
| Pinto, JA | 1 |
| Bonato, SJ | 1 |
| Aikawa, J | 1 |
| Yamazaki, RK | 1 |
| Pizato, N | 1 |
| Facin, M | 1 |
| Grohs, H | 1 |
| de Oliveira, HH | 1 |
| Naliwaiko, K | 1 |
| Ferraz, AC | 1 |
| Nishiyama, A | 1 |
| Patiyal, SN | 2 |
| Katoch, SS | 1 |
| Bonnet, N | 2 |
| Benhamou, CL | 2 |
| Brunet-Imbault, B | 2 |
| Arlettaz, A | 2 |
| Horcajada, MN | 2 |
| Richard, O | 1 |
| Vico, L | 1 |
| Collomp, K | 2 |
| Courteix, D | 2 |
| Akutsu, S | 1 |
| Shimada, A | 1 |
| Yamane, A | 1 |
| McDaneld, TG | 1 |
| Hannon, K | 1 |
| Moody, DE | 1 |
| Sharma, S | 1 |
| Mounier, R | 1 |
| Cavalié, H | 1 |
| Lac, G | 1 |
| Clottes, E | 1 |
| Shirato, K | 1 |
| Tanihata, J | 1 |
| Motohashi, N | 1 |
| Tachiyashiki, K | 1 |
| Tomoda, A | 1 |
| Imaizumi, K | 1 |
| Emery, PW | 1 |
| Rothwell, NJ | 11 |
| Stock, MJ | 7 |
| Winter, PD | 1 |
| Weppelman, RM | 1 |
| Amemiya, K | 1 |
| Kudoh, M | 1 |
| Suzuki, H | 1 |
| Saga, K | 1 |
| Hosaka, K | 1 |
| Ishizaki, O | 1 |
| Daidohji, S | 1 |
| Kimura, K | 1 |
| Shibuya, K | 1 |
| Horiguchi, T | 1 |
| Sekiwa, M | 1 |
| Dalrymple, RH | 1 |
| Baker, PK | 1 |
| Gingher, PE | 1 |
| Ingle, DL | 1 |
| Pensack, JM | 1 |
| Ricks, CA | 1 |
| Petrou, M | 2 |
| Wynne, DG | 1 |
| Boheler, KR | 1 |
| Yacoub, MH | 1 |
| Sillence, MN | 2 |
| Reich, MM | 1 |
| Thomson, BC | 1 |
| Martineau, L | 1 |
| Little, RA | 5 |
| Fisher, MI | 1 |
| Cartañà, J | 2 |
| Hayes, A | 1 |
| Williams, DA | 1 |
| Biolatti, B | 2 |
| Bollo, E | 1 |
| Re, G | 3 |
| Appino, S | 1 |
| Tartari, E | 1 |
| Benatti, G | 1 |
| Elliott, CT | 1 |
| McCaughey, WJ | 1 |
| Carter, WJ | 3 |
| Lynch, ME | 3 |
| Moore, NG | 1 |
| Pegg, GG | 1 |
| Segués, T | 1 |
| Yebras, M | 1 |
| Hyltander, A | 1 |
| Svaninger, G | 1 |
| Lundholm, K | 1 |
| Torgan, CE | 2 |
| Etgen, GJ | 1 |
| Brozinick, JT | 2 |
| Wilcox, RE | 2 |
| Ivy, JL | 5 |
| Banks, EA | 1 |
| Cortez, MY | 1 |
| Takahashi, K | 1 |
| Akiba, Y | 1 |
| Horiguchi, M | 1 |
| Badino, P | 2 |
| Dacasto, M | 1 |
| Nebbia, C | 1 |
| Di Carlo, F | 1 |
| Girardi, C | 2 |
| Agbenyega, ET | 2 |
| Morton, RH | 2 |
| Hatton, PA | 2 |
| Wareham, AC | 2 |
| Jentsch, W | 1 |
| Herrmann, U | 1 |
| Beyer, M | 1 |
| Michelchen, G | 1 |
| Hoffmann, L | 1 |
| Novelli, A | 1 |
| Kuo, CH | 1 |
| Ding, Z | 2 |
| Criswell, DS | 1 |
| Powers, SK | 1 |
| Herb, RA | 1 |
| Ingalls, CP | 1 |
| Barnes, WS | 1 |
| Smith, SB | 2 |
| Carbó, N | 1 |
| López-Soriano, J | 1 |
| Tarragó, T | 1 |
| González, O | 1 |
| Llovera, M | 1 |
| López-Soriano, FJ | 1 |
| Argilés, JM | 1 |
| Sharma, AK | 1 |
| Lee, YB | 1 |
| Murray, JD | 1 |
| Suzuki, J | 1 |
| Gao, M | 1 |
| Xie, Z | 1 |
| Koyama, T | 1 |
| Mozdziak, PE | 1 |
| Greaser, ML | 1 |
| Schultz, E | 1 |
| Cubría, JC | 1 |
| Reguera, R | 1 |
| Balaña-Fouce, R | 1 |
| Ordóñez, C | 1 |
| Ordóñez, D | 1 |
| Van Der Heijden, HF | 1 |
| Dekhuijzen, PN | 1 |
| Folgering, H | 1 |
| Ginsel, LA | 1 |
| Van Herwaarden, CL | 1 |
| Sawaya, AL | 1 |
| Lunn, PG | 1 |
| Ocampo, L | 1 |
| Cortez, U | 1 |
| Sumano, H | 1 |
| Avila, E | 1 |
| Groot, MJ | 1 |
| Schilt, R | 1 |
| Ossenkoppele, JS | 1 |
| Berende, PL | 1 |
| Haasnoot, W | 1 |
| Clarke, S | 1 |
| Morrison, K | 1 |
| Bowles, C | 1 |
| Dunn, M | 1 |
| Yacoub, M | 1 |
| Goalstone, ML | 1 |
| Wall, K | 1 |
| Leitner, JW | 1 |
| Kurowski, T | 1 |
| Ruderman, N | 1 |
| Pan, SJ | 2 |
| Moller, DE | 1 |
| Draznin, B | 1 |
| Murphy, RJ | 1 |
| Béliveau, L | 2 |
| Gardiner, PF | 1 |
| Calderone, A | 2 |
| Illera, JC | 1 |
| Silván, G | 1 |
| Blass, A | 1 |
| Martínez, MM | 1 |
| Illera, M | 1 |
| Ricart-Firinga, C | 1 |
| Stevens, L | 2 |
| Canu, MH | 1 |
| Nemirovskaya, TL | 1 |
| Mounier, Y | 2 |
| Lynch, GS | 1 |
| Hinkle, RT | 1 |
| Faulkner, JA | 1 |
| Chen, KD | 2 |
| Alway, SE | 2 |
| Firinga, C | 1 |
| Gohlsch, B | 1 |
| Bastide, B | 1 |
| Pette, D | 1 |
| Hancock, J | 1 |
| Fogt, D | 1 |
| Lee, M | 1 |
| Lavoie, JL | 1 |
| Kitaura, T | 1 |
| Tsunekawa, N | 1 |
| Kraemer, WJ | 1 |
| von Deutsch, DA | 1 |
| Abukhalaf, IK | 1 |
| Wineski, LE | 1 |
| Roper, RR | 1 |
| Aboul-Enein, HY | 1 |
| Paulsen, DF | 1 |
| Potter, DE | 1 |
| Choo, JJ | 4 |
| Horan, MA | 4 |
| Belahsen, R | 1 |
| Deshaies, Y | 1 |
| Benson, DW | 1 |
| Foley-Nelson, T | 1 |
| Chance, WT | 2 |
| Zhang, FS | 2 |
| James, JH | 1 |
| Fischer, JE | 2 |
| Peréz-Llamas, F | 1 |
| Sastre, JF | 1 |
| Zamora, S | 1 |
| Wareham, A | 1 |
| Maltin, CA | 1 |
| Delday, MI | 1 |
| Hay, SM | 2 |
| Katsumata, M | 2 |
| Yano, H | 2 |
| Miyazaki, A | 2 |
| Dang, AQ | 1 |
| Faas, FH | 1 |
| von Allmen, D | 1 |
| Benson, D | 1 |
| Ishida, N | 1 |
| Francès, H | 1 |
| Raisman, R | 1 |
| Simon, P | 1 |
| Struck, I | 1 |
| McElligott, MA | 2 |
| Barreto, A | 2 |
| Chaung, LY | 2 |
| Claeys, MC | 1 |
| Mulvaney, DR | 1 |
| McCarthy, FD | 1 |
| Gore, MT | 1 |
| Marple, DN | 1 |
| Sartin, JL | 1 |
| Babij, P | 1 |
| Booth, FW | 1 |
| Hu, CY | 1 |
| Novakofski, J | 1 |
| Mersmann, HJ | 1 |
| Sudera, DK | 1 |
| Mulder, JE | 1 |
| Miller, MF | 1 |
| Garcia, DK | 1 |
| Coleman, ME | 1 |
| Ekeren, PA | 1 |
| Lunt, DK | 1 |
| Wagner, KA | 1 |
| Procknor, M | 1 |
| Welsh, TH | 1 |
| Williams, PE | 1 |
| Pagliani, L | 1 |
| Innes, GM | 1 |
| Pennie, K | 1 |
| Harris, CI | 1 |
| Garthwaite, P | 1 |
| Reeds, PJ | 1 |
| Dorwood, PM | 1 |
| Palmer, RM | 1 |
| Bohorov, O | 1 |
| Buttery, PJ | 1 |
| Correia, JH | 1 |
| Soar, JB | 1 |
1 review available for clenbuterol and Body Weight
| Article | Year |
|---|---|
Effects of gonadal steroids and adrenergic agonists on avian growth and feed efficiency.
Topics: Adrenergic Agonists; Animal Feed; Animals; Body Weight; Clenbuterol; Diethylstilbestrol; Energy Meta | 1984 |
1 trial available for clenbuterol and Body Weight
| Article | Year |
|---|---|
Use of low doses of clenbuterol to reduce incidence of ascites syndrome in broilers.
Topics: Adrenergic beta-Agonists; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ascites; | 1998 |
93 other studies available for clenbuterol and Body Weight
| Article | Year |
|---|---|
Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth.
Topics: Animals; Body Weight; Clenbuterol; Gene Expression Regulation; Male; Mice; Muscle Proteins; Muscle, | 2018 |
Single injection of the β2-adrenergic receptor agonist, clenbuterol, into newly hatched chicks alters abdominal fat pad mass in growing birds.
Topics: Abdominal Fat; Adipose Tissue; Adrenergic beta-Agonists; Animals; Body Weight; Chickens; Clenbuterol | 2015 |
Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Topics: Administration, Oral; Animals; Body Weight; Clenbuterol; Dexamethasone; Energy Metabolism; Feeding B | 2015 |
Beta2-adrenergic agonist-induced hypertrophy of the quadriceps skeletal muscle does not modulate disease severity in the rodent meniscectomy model of osteoarthritis.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Disease Models, Animal; Hypertrophy; Ma | 2010 |
Effects of co-administration of clenbuterol and testosterone propionate on skeletal muscle in paraplegic mice.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Androgens; Animals; Body Weight; Clenbuterol; Drug I | 2010 |
Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Calcium-Transporting ATPases; Clenbuterol; Disease M | 2002 |
Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres.
Topics: Animals; Body Weight; Clenbuterol; Electrophoresis, Polyacrylamide Gel; Heart; Male; Muscle Fibers, | 2002 |
Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cachexia; Carcinoma 256, Walker; Clen | 2003 |
beta-Adrenergic receptor agonists increase apoptosis of adipose tissue in mice.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Animals; Apoptosis; Body Composition; Body Temperature; Bo | 2004 |
Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
Topics: Adrenergic beta-Agonists; Animals; Blotting, Western; Body Weight; Clenbuterol; Female; Immunohistoc | 2004 |
Effect of thyroid hormone on uncoupling protein-3 mRNA expression in rat heart and skeletal muscle.
Topics: Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Body Weight; Captopril; Carrier Proteins | 2004 |
Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats.
Topics: Animals; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Female; Fish Oils; Insulin; Napr | 2004 |
Tissue specific and variable collagen proliferation in Swiss albino mice treated with clenbuterol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Body Weight; Butoxamine; Clenbuterol | 2006 |
Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; | 2005 |
Alteration of trabecular bone under chronic beta2 agonists treatment.
Topics: Adipose Tissue; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; B | 2005 |
Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Fibroblast Growth Factors; Hepatocyte G | 2006 |
Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle.
Topics: Adrenergic beta-Agonists; Animals; Animals, Genetically Modified; Body Weight; Cattle; Cell Differen | 2006 |
Chronic oral administration of beta-adrenoceptor agonist clenbuterol affects myosin heavy chain (MHC) expression in adult mouse heart.
Topics: Administration, Oral; Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Heart Ventricles; | 2007 |
Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Citrate (si)-Synthase; Clenbuterol; Creatine Kinase; | 2007 |
Beta2-agonist clenbuterol induced changes in the distribution of white blood cells in rats.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Erythrocytes; Hemoglobins; Leukocyte Co | 2007 |
Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat.
Topics: Adipose Tissue, Brown; Adrenergic beta-Agonists; Animals; Body Composition; Body Weight; Clenbuterol | 1984 |
Toxicology of mabuterol.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Bronchodilator Agents; Capsules; Clenbuterol; Dogs; | 1984 |
Reproduction studies with mabuterol in rats.
Topics: Adrenergic beta-Agonists; Animals; Animals, Suckling; Birth Weight; Body Weight; Bronchodilator Agen | 1984 |
A repartitioning agent to improve performance and carcass composition of broilers.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Chickens; Clenbuterol; Energy Metabolism; Et | 1984 |
Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes.
Topics: Adipose Tissue; Animals; Base Sequence; Body Weight; Cardiomegaly; Clenbuterol; Forelimb; Hypertroph | 1995 |
Sexual dimorphism in the growth response of entire and gonadectomized rats to clenbuterol.
Topics: Animals; Body Weight; Clenbuterol; Feeding Behavior; Female; Growth; Male; Orchiectomy; Organ Size; | 1995 |
Clenbuterol, a beta 2-adrenergic agonist, reverses muscle wasting due to scald injury in the rat.
Topics: Animals; Body Weight; Burns; Clenbuterol; Male; Muscles; Muscular Atrophy; Proteins; Rats; Rats, Spr | 1993 |
Effects of clenbuterol and salbutamol on tissue rubidium uptake in vivo.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Albuterol; Animals; Body Weight; Clenbuterol; Ma | 1995 |
Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Topics: Animals; Body Weight; Clenbuterol; Dystrophin; Heart; Histocytochemistry; Isometric Contraction; Mal | 1994 |
Pathology and residues in veal calves treated experimentally with clenbuterol.
Topics: Animals; Body Weight; Cattle; Cattle Diseases; Clenbuterol; Drug Residues; Female; Genitalia, Female | 1994 |
Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats.
Topics: Adrenergic beta-Agonists; Aging; Albuterol; Animals; Body Composition; Body Weight; Clenbuterol; Cre | 1994 |
Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Animals; Appetite; Body Weight; Clenbuter | 1994 |
Effect of clenbuterol on recovery of muscle mass and carcass protein content following dietary protein depletion in young and old rats.
Topics: Aging; Animals; Body Composition; Body Water; Body Weight; Clenbuterol; Creatine; Creatinine; Dietar | 1994 |
Anabolic effects of clenbuterol after long-term treatment and withdrawal in t the rat.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Clenbuterol; Diet; Eating; Epididymis; Injec | 1994 |
The effect of clenbuterol on body composition in spontaneously eating tumour-bearing mice.
Topics: Animals; Body Composition; Body Weight; Cachexia; Clenbuterol; Eating; Female; Mice; Mice, Inbred C5 | 1993 |
Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle.
Topics: Aerobiosis; Animals; Body Weight; Citrate (si)-Synthase; Clenbuterol; Enzymes; Female; Glucose; Hind | 1993 |
Exercise training and clenbuterol reduce insulin resistance of obese Zucker rats.
Topics: 3-O-Methylglucose; Animals; Biological Transport; Body Weight; Citrate (si)-Synthase; Clenbuterol; D | 1993 |
Effects of a beta-adrenergic agonist (clenbuterol) on performance, carcase composition, hepatic microsomal mixed function oxidase and antibody production in female broilers treated with or without corticosterone.
Topics: Animals; Antibodies, Bacterial; Body Weight; Brucella abortus; Chickens; Clenbuterol; Corticosterone | 1993 |
Effects of long-term administration of clenbuterol in mature female rats.
Topics: 7-Alkoxycoumarin O-Dealkylase; Aniline Hydroxylase; Animals; Body Weight; Clenbuterol; Cytochrome P- | 1993 |
Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse.
Topics: Administration, Oral; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Body W | 1995 |
Investigations on the influence of Clenbuterol and recombinant porcine somatotropin on nitrogen and energy metabolism in growing pigs.
Topics: Aging; Animals; Body Weight; Calorimetry; Clenbuterol; Diet; Energy Metabolism; Growth Hormone; Nitr | 1993 |
Down-regulation of beta-adrenergic receptors and up-regulation of estrogen and progesterone receptors induced in the reproductive system of female veal calves by dietary clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Body Weight; Cattle; Clenbuterol; Diet; Down-Re | 1995 |
Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; C | 1996 |
Clenbuterol-induced fiber type transition in the soleus of adult rats.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Electrophoresis, Polyacrylamide Gel; Fe | 1996 |
Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content.
Topics: Animals; Body Weight; Clenbuterol; Gene Expression; Male; Mice; Mice, Inbred ICR; Muscle, Skeletal; | 1996 |
Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anima | 1995 |
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Body Weight; Cachexia; Clenbuterol; Ea | 1997 |
The response of transgenic mice to beta-adrenergic agonist administration is different from that of normal mice.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Weight; Cathepsins; Clenbuterol; DNA; Female; Genotyp | 1997 |
Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aging; Animals; Body Weight; Capillar | 1997 |
Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Northern; Body Weight; Clenbuterol; Female; Hypertro | 1998 |
Polyamine-mediated heart hypertrophy induced by clenbuterol in the mouse.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Cardiomegaly; Clenbuterol; Heart; Male; Mice; Mice, | 1998 |
Long-term effects of clenbuterol on diaphragm morphology and contractile properties in emphysematous hamsters.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Cricetinae; Diaphragm; Male; Mesocricet | 1998 |
Increase in skeletal muscle protein content by the beta-2 selective adrenergic agonist clenbuterol exacerbates hypoalbuminemia in rats fed a low-protein diet.
Topics: Adipose Tissue, Brown; Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Diet, Protein-Re | 1998 |
Combinations of growth promoters in veal calves: consequences for screening and confirmation methods.
Topics: 2-Hydroxyphenethylamine; Adrenergic beta-Agonists; Aniline Compounds; Animals; Body Constitution; Bo | 1998 |
Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardiac assist.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Drug Evaluation, Preclinical; Electric | 1999 |
Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Aurothioglucose; Blood Glucose; Body Weight; Clenbu | 1999 |
Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Body Weight; Calcium; Calcium Channels; Calcium C | 1999 |
The effect of clenbuterol on adrenal function in rats.
Topics: Adrenal Glands; Adrenergic beta-Agonists; Anabolic Agents; Animals; Body Weight; Clenbuterol; Female | 1998 |
Effects of beta(2)-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Calcium; Clenbuterol; Hindlimb Suspension; In Vitro | 2000 |
Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Energy Metabolism; In Vitro Techniques; | 2000 |
A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Weight; Clenbuterol; Isometric Contraction; Male; Mus | 2000 |
Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat.
Topics: Adrenergic beta-Agonists; Animals; Atrophy; Body Weight; Clenbuterol; Hindlimb; Hindlimb Suspension; | 2000 |
Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Weight; Clenbuterol; Eating; Isometric Contraction; M | 2001 |
Effects of clenbuterol on insulin resistance in conscious obese Zucker rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Clenbuterol; Female; Glucose; Glycoge | 2001 |
A farnesyltransferase inhibitor attenuated beta-adrenergic receptor downregulation in rat skeletal muscle.
Topics: Adrenergic beta-Agonists; Alkyl and Aryl Transferases; Animals; Animals, Newborn; Body Weight; Cells | 2002 |
Inhibited longitudinal growth of bones in young male rats by clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Bone Density; Bone Development; Clenbuterol; Femur; | 2002 |
Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Hindlimb Suspension; Ma | 2002 |
Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.
Topics: Albuterol; Animals; Body Weight; Clenbuterol; Dose-Response Relationship, Drug; Male; Muscles; Organ | 1992 |
Modulation of lipoprotein lipase activity in the rat by the beta 2-adrenergic agonist clenbuterol.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cholesterol; Clenbute | 1992 |
Decreased myofibrillar protein breakdown following treatment with clenbuterol.
Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Clenbuterol; Eating; Male; Methylhistidines; Musc | 1991 |
Influence of dietary protein level on growth: effect of clenbuterol.
Topics: Animals; Body Weight; Clenbuterol; Dietary Proteins; Female; Food Additives; Muscle Development; Mus | 1991 |
Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Ethanolamines; Fasting; Food Deprivatio | 1990 |
Anabolic beta-2-agonist clenbuterol fails to modify muscle atrophy due to femur fracture.
Topics: Adipose Tissue, Brown; Animals; Body Weight; Clenbuterol; Eating; Femoral Fractures; Male; Muscle Pr | 1990 |
The effect of clenbuterol administration in utero and throughout lactation on pre- and post-natal muscle development in the rat.
Topics: Adenosine Triphosphatases; Administration, Oral; Animals; Body Weight; Clenbuterol; Embryonic and Fe | 1990 |
Effect of beta agonist clenbuterol on the body composition of rats with hypothyroidism induced by oral administration of propylthiouracil.
Topics: Adipose Tissue; Animals; Body Composition; Body Weight; Cholesterol; Clenbuterol; Hypothyroidism; Li | 1991 |
Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats.
Topics: Aging; Animals; Body Composition; Body Weight; Clenbuterol; Eating; Heart; Heart Ventricles; Infusio | 1991 |
Clenbuterol decreases catabolism and increases hypermetabolism in burned rats.
Topics: Amino Acids; Animals; Body Weight; Burns; Clenbuterol; Drinking; Eating; Energy Metabolism; Muscles; | 1991 |
Influence of a high ambient temperature and administration of clenbuterol on body composition in rats.
Topics: Administration, Oral; Animals; Body Composition; Body Weight; Clenbuterol; Male; Rats; Rats, Inbred | 1990 |
Lesions of the serotonergic system impair the facilitation of but not the tolerance to the effects of chronic clenbuterol administration.
Topics: 5,7-Dihydroxytryptamine; Animals; Body Temperature; Body Weight; Brain Chemistry; Clenbuterol; Drug | 1987 |
Effect of continuous and intermittent clenbuterol feeding on rat growth rate and muscle.
Topics: Acetylglucosaminidase; Animal Feed; Animals; Body Weight; Cathepsin B; Cathepsin D; Clenbuterol; Eth | 1989 |
Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol.
Topics: Animal Feed; Animals; Body Weight; Clenbuterol; Eating; Ethanolamines; Growth Hormone; Least-Squares | 1989 |
Muscle wasting associated with endotoxemia in the rat: modification by the beta 2-adrenoceptor agonist clenbuterol.
Topics: Animals; Body Weight; Clenbuterol; Endotoxins; Ethanolamines; Male; Muscular Atrophy; Rats; Rats, In | 1989 |
Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle.
Topics: Actins; Animals; Body Weight; Clenbuterol; Cytochrome c Group; Denervation; Ethanolamines; Female; H | 1988 |
Clenbuterol stimulated increase of plasma free fatty acids in reserpinized pigs.
Topics: Animals; Blood Pressure; Body Weight; Catecholamines; Clenbuterol; Ethanolamines; Fatty Acids, Nones | 1988 |
Changes in tissue blood flow and beta-receptor density of skeletal muscle in rats treated with the beta2-adrenoceptor agonist clenbuterol.
Topics: Animals; Body Weight; Clenbuterol; Dihydroalprenolol; Ethanolamines; Male; Microspheres; Muscle Prot | 1987 |
Clenbuterol-induced muscle growth: investigation of possible mediation by insulin.
Topics: Acetylglucosaminidase; Animals; Blood Glucose; Body Weight; Cathepsin B; Clenbuterol; Eating; Ethano | 1987 |
Adipose tissue, longissimus muscle and anterior pituitary growth and function in clenbuterol-fed heifers.
Topics: Adipose Tissue; Animals; Body Weight; Cattle; Clenbuterol; Ethanolamines; Female; Muscle Development | 1988 |
Influence of clenbuterol on energy balance, thermogenesis and body composition in lean and genetically obese Zucker rats.
Topics: Adipose Tissue, Brown; Animals; Body Composition; Body Temperature Regulation; Body Weight; Clenbute | 1987 |
Effect of a selective beta 2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats.
Topics: Animals; Body Composition; Body Weight; Clenbuterol; Dietary Proteins; Energy Metabolism; Ethanolami | 1987 |
Effects of a beta-agonist (clenbuterol) on growth, carcass composition, protein and energy metabolism of veal calves.
Topics: Adipose Tissue; Animal Feed; Animals; Body Composition; Body Weight; Cattle; Clenbuterol; Energy Met | 1987 |
Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis.
Topics: Animals; Body Weight; Clenbuterol; Ethanolamines; Female; Male; Muscle Development; Muscle Proteins; | 1986 |
The effect of the beta-2-adrenergic agonist clenbuterol or implantation with oestradiol plus trenbolone acetate on protein metabolism in wether lambs.
Topics: Animals; Body Weight; Clenbuterol; Drug Implants; Estradiol; Estrenes; Ethanolamines; Male; Muscle P | 1987 |
Modification of body composition by clenbuterol in normal and dystrophic (mdx) mice.
Topics: Animals; Body Composition; Body Weight; Clenbuterol; Energy Metabolism; Ethanolamines; Female; Mice; | 1985 |